Peanut Allergy Vaccine Market - By Product Type (), By Application (Hospitals, Personal Clinics and Government Agencies), By Drug Type (Epinephrine Injection (EpiPen, Twinject, AUVI-Q), Antihistamines), By Route of Administration (Oral, Injectable), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Store) and By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 184
Status: Published
Report Code: ARI100358
An Allergy is a damaging immune response by the body system to a substance, especially a particular food, pollen, fur, or dust, to which it has become receptive. Peanut allergy occurs when your immune system mistakenly identifies peanut proteins as something dangerous. Direct or indirect contact with peanuts causes your immune system to release symptom-causing chemicals into your bloodstream. It thereby results in adverse reactions that can range from mild hives, cramps, nausea and vomiting to life threatening anaphylactic reactions that demands immediate medical attention. Severe allergic reactions can also include impaired breathing, swelling in the throat, a sudden drop in blood pressure, dizziness, and even death. Globally, the incidence of food allergies and related life-threatening anaphylaxis has been increasing in a tremendous manner, with the World Allergy Organization reporting 220-550 million people are affected.
In accordance to the American Journal of Scientific Medicines Research 2016 findings, peanut allergy is one of the most commonly found allergy in children. every year its affect is seen in 2.5% to 3% of the pediatric population in US. The major market players in peanut allergy vaccine market are Aimmune Therapeutics, DBV Technologies, Prota Therapeutics, Cambridge Allergy, Sanofi, Aravax, AnaptysBio, Astellas Pharma, Immunomic Therapeutics, HAL Allergy, and others.
Analyst commentary
The people with weak digestive system generally are at the risk of being infected by Peanut allergy, which mainly includes Children, especially toddlers and infants and also the old-aged people. It is found that Peanut allergies tend to be lifelong, although studies show that about 20 percent of children with peanut allergy do eventually outgrow their allergy, which makes us believe that if once infected, the children have very less chance to get rid of this allergy.
Also, after people with peanut allergy received oral immunotherapy to induce tolerance to peanut, most who discontinued or had a reduced dose lost the therapy's protective effects. Researchers found markers in blood that could predict the success of therapy, suggesting a test to help identify those who could benefit from it.
Many companies have been working on the peanut allergy vaccines. Studies says that North America holds a Major Share of Global Peanut Allergy Treatment Market. North America is likely to dominate the global peanut allergy treatment market, followed by Europe and Asia Pacific. This dominance is mainly due to the US having a large population of potential patients (approximately 3,000,000 probables diagnosed prevalent cases), an elevated expected price tag for new therapies (5–7 times that of the other geographies), and a higher expected treatment rate (based on good accessibility to allergy specialists).
Globally, the incidence of peanut allergy is increasingly supported by rising birth rate. According to American Academy of Allergy Asthma & Immunology, the children with food allergies that suffered from multiple allergy attacks are 30.4%. Peanut allergy is such a plague condition in the U.S. that the federal Food Allergen Labelling and Consumer Protection Act (FALCPA) ordered that all packaged food sold in the U.S. that include peanuts as an ingredient have to highlight the word 'Peanut' on the label. The only solution as yet for peanut allergy is preventing a patient from having peanuts/peanuts containing products. Nevertheless, peanut vaccine is capable of curing the disorder from a very young age, without any restriction on food.
Segmentation:
Peanut allergy medicine market is segmented on various types by Product Type, by Application, By Drug type, By Route of administration, By Distribution channel and By Regions. The Detailed analysis of the segmentation is done below:
By Product Type: ASP0892, AR101. Others (oral immunotherapy and via skin peanuts)
Based on oral food challenges outcomes, AR101 appears more effective than Viaskin Peanut, but appears to have more adverse effects. However, the level of certainty in the comparative evidence is low (insufficient). It is observed that AR101 is sold more in the market than any other vaccine for peanut allergy.
By Application: Hospitals, Personal Clinics, Government Agencies
For the application-based segmentation, it was found that hospitals are more likely to use the vaccine for the peanut allergy than the personal clinics and the government agencies. The hospitals carry around 3/5 of the market share for the same followed by personal clinics and then the government agencies.
By Drug Type: Epinephrine Injection (EpiPen, Twinject, AUVI-Q), Antihistamines
For a severe allergic reaction, you may need an emergency injection of epinephrine and to visit the emergency room. Many people with allergies carry an epinephrine autoinjector (EpiPen, Auvi-Q). For a mild reaction, to reduce your symptoms you may only need to take an antihistamine, such as a no drowsy one like loratadine (Claritin) or some sleep driving medicine like diphenhydramine (Benadryl). Thus, as more people generally have mild reactions only so the Antihistamines are more in use than the Epinephrine injection.
By Route of Administration: Oral, Injectable
For a mild reaction of the peanut allergy, the patient is advised to take the medication for which the route of administration is oral whereas for the severe infections, Epinephrine injectors are preferred. Thus, the oral route of administration is more in use because of the less severe cases among the patients.
By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Store
In terms of the Distribution Channel, the Market for the peanut allergy vaccine is dominated by the Hospital pharmacies because it can’t be known until you meet the doctor in the hospitals, followed by retail pharmacies and drug stores because over the counter (OTC) medicines is one that the U.S. Food and Drug Administration (FDA) has found to be safe and effective for direct consumer use based on the label instructions and warnings.
Regional Analysis:
Studies says that North America holds a Major Share of Global Peanut Allergy Treatment Market. North America is likely to dominate the global peanut allergy treatment market, followed by Europe and Asia Pacific. This dominance is mainly due to the US having a large population of potential patient Peanut allergy treatment market in Europe and Asia Pacific is also anticipated to witness substantial growth during the forecast period due to rise in the number of food related allergy testing and per capita health care spending by the regions. Peanuts are one of the most common food allergies and is the most likely food to cause anaphylaxis or death. In Australia, there is particularly high presence of peanut allergies with one in 200 adults, and almost three in every 100 children affected. It is more common in people with lower income (1.7% vs. 1.2%), males (1.7% vs. 0.8%), and there are race/ethnicity disparities in the prevalence of peanut allergies (1.7% Hispanics, 2.8% non-Hispanic blacks and 0.9% non-Hispanic whites)
Table of Contents
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. Global Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
4.1. Global Peanut Allergy Vaccine Share, By Application, 2015 - 2026 (USD Million) (Million Units)
4.1.1. Hospitals
4.1.1.1. Market Size and projections,2015 - 2026 (USD Million) (Million Units)
4.1.1.2. Market Size and Projections, by Region, 2015 - 2026 (USD Million) (Million Units)
4.1.2. Personal Clinics
4.1.2.1. Market Size and projections,2015 - 2026 (USD Million) (Million Units)
4.1.2.2. Market Size and Projections, by Region, 2015 - 2026 (USD Million) (Million Units)
4.1.3. Government Agencies
4.1.3.1. Market Size and Projections, 2015 - 2026 (USD Million) Million Units)
4.1.3.2. Market Size and Projections, by Region, 2015 - 2026 (USD Million) (Million Units)
4.1.4. Others
4.1.4.1. Market Size and Projections, 2015 - 2026 (USD Million) (Million Units)
4.1.4.2. Market Size and Projections, by Region, 2015 - 2026 (USD Million) (Million Units)
Chapter 5. Global Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
5.1. Global Peanut Allergy Vaccine Share, By Product, 2015 - 2026 (USD Million) (Million Units)
5.1.1. ASP0892
5.1.1.1. Market Size and Projections,2015 - 2026 (USD Million) (Million Units)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2026 (USD Million) (Million Units)
5.1.2. AR101
5.1.2.1. Market Size and Projections, 2015 - 2026 (USD Million) (Million Units)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2026 (USD Million) (Million Units)
5.1.3. Others
5.1.3.1. Market Size and Projections, 2015 - 2026 (USD Million) (Million Units)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2026 (USD Million) (Million Units)
Chapter 6. Global Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
6.1. Global Peanut Allergy Vaccine Share, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
6.1.1. Epinephrine Injection (EpiPen, Twinject, AUVI-Q)
6.1.1.1. Market Size and Projections,2015 - 2026 (USD Million) (Million Units)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2026 (USD Million) (Million Units)
6.1.2. Antihistamines
6.1.2.1. Market Size and Projections, 2015 - 2026 (USD Million) (Million Units)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2026 (USD Million) (Million Units)
Chapter 7. Global Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
7.1. Global Peanut Allergy Vaccine Share, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
7.1.1. Oral
7.1.1.1. Market Size and Projections,2015 - 2026 (USD Million) (Million Units)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2026 (USD Million) (Million Units)
7.1.2. Injectable
7.1.2.1. Market Size and Projections, 2015 - 2026 (USD Million) (Million Units)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2026 (USD Million) (Million Units)
Chapter 8. Global Peanut Allergy Vaccine Market Overview, By Distribution Channel, 2015 - 2026 (USD Million) (Million Units)
8.1. Global Peanut Allergy Vaccine Share, By Distribution Channel, 2015 - 2026 (USD Million) (Million Units)
8.1.1. Retail Pharmacies
8.1.1.1. Market Size and Projections,2015 - 2026 (USD Million) (Million Units)
8.1.1.2. Market Size and Projections, by Region, 2015 - 2026 (USD Million) (Million Units)
8.1.2. Hospital Pharmacies
8.1.2.1. Market Size and Projections, 2015 - 2026 (USD Million) (Million Units)
8.1.2.2. Market Size and Projections, by Region, 2015 - 2026 (USD Million) (Million Units)
8.1.3. Online Pharmacies
8.1.3.1. Market Size and Projections,2015 - 2026 (USD Million) (Million Units)
8.1.3.2. Market Size and Projections, by Region, 2015 - 2026 (USD Million) (Million Units)
8.1.4. Drug Store
8.1.4.1. Market Size and Projections, 2015 - 2026 (USD Million) (Million Units)
8.1.4.2. Market Size and Projections, by Region, 2015 - 2026 (USD Million) (Million Units)
Chapter 9. Global Peanut Allergy Vaccine Market Overview, By Geography, 2015 - 2026 (USD Million) (Million Units)
9.1. Global Peanut Allergy Vaccine Share, By Geography, 2015 - 2026 (USD Million) (Million Units)
9.1.1. Market Size and projections, by Countries, 2015 - 2026 (USD Million) (Million Units)
9.1.2. Market Share and CAGR Comparison, by Countries, 2018 (%)
Chapter 10. North America Peanut Allergy Vaccine Market Overview, By Countries, 2015 - 2026 (USD Million) (Million Units)
10.1. North America Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
10.1.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
10.1.2. North America Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
10.1.3. North America Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
10.1.4. North America Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
10.1.5. North America Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
10.1.6. North America Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
10.1.7. North America Peanut Allergy Vaccine Market Overview, By Countries, 2015 - 2026 (USD Million) (Million Units)
10.1.7.1. U.S. Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
10.1.7.1.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
10.1.7.1.2. U.S. Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
10.1.7.1.3. U.S. Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
10.1.7.1.4. U.S. Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
10.1.7.1.5. U.S. Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
10.1.7.1.6. U.S. Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
10.1.7.2. Canada Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
10.1.7.2.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
10.1.7.2.2. Canada Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
10.1.7.2.3. Canada Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
10.1.7.2.4. Canada Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
10.1.7.2.5. Canada Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
10.1.7.2.6. Canada Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
10.1.7.3. Mexico Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
10.1.7.3.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
10.1.7.3.2. Mexico Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
10.1.7.3.3. Mexico Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
10.1.7.3.4. Mexico Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
10.1.7.3.5. Mexico Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
10.1.7.3.6. Mexico Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
Chapter 11. Europe Peanut Allergy Vaccine Market Overview, By Countries, 2015 - 2026 (USD Million) (Million Units)
11.1. Europe Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
11.1.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
11.1.2. Europe Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
11.1.3. Europe Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
11.1.4. Europe Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
11.1.5. Europe Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
11.1.6. Europe Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
11.1.7. Europe Peanut Allergy Vaccine Market Overview, By Countries, 2015 - 2026 (USD Million) (Million Units)
11.1.7.1. Germany Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
11.1.7.1.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
11.1.7.1.2. Germany Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
11.1.7.1.3. Germany Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
11.1.7.1.4. Germany Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
11.1.7.1.5. Germany Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
11.1.7.1.6. Germany Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
11.1.7.2. France Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
11.1.7.3. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
11.1.7.3.1. France Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
11.1.7.3.2. France Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
11.1.7.3.3. France Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
11.1.7.3.4. France Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
11.1.7.3.5. France Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
11.1.7.4. UK Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
11.1.7.4.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
11.1.7.4.2. UK Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
11.1.7.4.3. UK Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
11.1.7.4.4. UK Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
11.1.7.4.5. UK Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
11.1.7.4.6. UK Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
11.1.7.5. Italy Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
11.1.7.5.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
11.1.7.5.2. Italy Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
11.1.7.5.3. Italy Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
11.1.7.5.4. Italy Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
11.1.7.5.5. Italy Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
11.1.7.5.6. Italy Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
11.1.7.6. Spain
11.1.7.6.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
11.1.7.6.2. Spain Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
11.1.7.6.3. Spain Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
11.1.7.6.4. Spain Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
11.1.7.6.5. Spain Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
11.1.7.6.6. Spain Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
11.1.7.7. Rest of Europe Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
11.1.7.7.1. Market size and projections, 2015 – 2025(USD Million) (Million Units)
11.1.7.7.2. Rest of Europe Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
11.1.7.7.3. Rest of Europe Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
11.1.7.7.4. Rest of Europe Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
11.1.7.7.5. Rest of Europe Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
11.1.7.7.6. Rest of Europe Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
Chapter 12. Asia Pacific Peanut Allergy Vaccine Market Overview, By Countries, 2015 - 2026 (USD Million) (Million Units)
12.1. Asia Pacific Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
12.1.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
12.1.2. Asia Pacific Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
12.1.3. Asia Pacific Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
12.1.4. Asia Pacific Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
12.1.5. Asia Pacific Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
12.1.6. Asia Pacific Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
12.1.7. Asia Pacific Peanut Allergy Vaccine Market Overview, By Countries, 2015 - 2026 (USD Million) (Million Units)
12.1.7.1. India Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
12.1.7.1.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
12.1.7.1.2. India Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
12.1.7.1.3. India Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
12.1.7.1.4. India Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
12.1.7.1.5. India Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
12.1.7.1.6. India Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
12.1.7.2. China Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
12.1.7.2.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
12.1.7.2.2. China Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
12.1.7.2.3. China Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
12.1.7.2.4. China Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
12.1.7.2.5. China Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
12.1.7.2.6. China Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
12.1.7.3. Japan Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
12.1.7.3.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
12.1.7.3.2. Japan Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
12.1.7.3.3. Japan Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
12.1.7.3.4. Japan Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
12.1.7.3.5. Japan Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
12.1.7.3.6. Japan Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
12.1.7.4. South Korea Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
12.1.7.4.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
12.1.7.4.2. South Korea Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
12.1.7.4.3. South Korea Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
12.1.7.4.4. South Korea Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
12.1.7.4.5. South Korea Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
12.1.7.4.6. South Korea Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
12.1.7.5. Rest of Asia Pacific Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
12.1.7.5.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
12.1.7.5.2. Rest of Asia Pacific Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
12.1.7.5.3. Rest of Asia Pacific Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
12.1.7.5.4. Rest of Asia Pacific Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
12.1.7.5.5. Rest of Asia Pacific Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
12.1.7.5.6. Rest of Asia Pacific Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
Chapter 13. Middle East & Africa Peanut Allergy Vaccine Market Overview, By Countries, 2015 - 2026 (USD Million) (Million Units)
13.1. Middle East & Africa Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
13.1.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
13.1.2. Middle East & Africa Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
13.1.3. Middle East & Africa Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
13.1.4. Middle East & Africa Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
13.1.5. Middle East & Africa Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
13.1.6. Middle East & Africa Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
13.1.7. Middle East & Africa Peanut Allergy Vaccine Market Overview, By Countries, 2015 - 2026 (USD Million) (Million Units)
13.1.7.1. GCC Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
13.1.7.1.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
13.1.7.1.2. GCC Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
13.1.7.1.3. GCC Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
13.1.7.1.4. GCC Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
13.1.7.1.5. GCC Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
13.1.7.1.6. GCC Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
13.1.7.2. South Africa Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
13.1.7.2.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
13.1.7.2.2. South Africa Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
13.1.7.2.3. South Africa Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
13.1.7.2.4. South Africa Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
13.1.7.2.5. South Africa Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
13.1.7.2.6. South Africa Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
13.1.7.3. Rest of Middle East & Africa Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
13.1.7.3.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
13.1.7.3.2. Rest of Middle East & Africa Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
13.1.7.3.3. Rest of Rest of Middle East & Africa Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
13.1.7.3.4. Rest of Middle East & Africa Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
13.1.7.3.5. Rest of Middle East & Africa Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
13.1.7.3.6. Rest of Middle East & Africa Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
Chapter 14. South America Peanut Allergy Vaccine Market Overview, By Countries, 2015 - 2026 (USD Million) (Million Units)
14.1. South America Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
14.1.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
14.1.2. South America Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
14.1.3. South America Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
14.1.4. South America Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
14.1.5. South America Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
14.1.6. South America Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
14.1.7. South America Peanut Allergy Vaccine Market Overview, By Countries, 2015 - 2026 (USD Million) (Million Units)
14.1.7.1. Brazil Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
14.1.7.1.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
14.1.7.1.2. Brazil Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
14.1.7.1.3. Brazil Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
14.1.7.1.4. Brazil Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
14.1.7.1.5. Brazil Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
14.1.7.1.6. Brazil Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
14.1.7.2. Argentina Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
14.1.7.2.1. Market size and projections, 2015 - 2026 (USD Million) (Million Units)
14.1.7.2.2. Argentina Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
14.1.7.2.3. Argentina Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
14.1.7.2.4. Argentina Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
14.1.7.2.5. Argentina Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
14.1.7.2.6. Argentina Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
14.1.7.3. Rest of South America Peanut Allergy Vaccine Market Overview, 2015 - 2026 (USD Million) (Million Units)
14.1.7.3.1. Market size and projections, 2015 – 2026
14.1.7.3.2. Rest of South America Peanut Allergy Vaccine Market Overview, By Application, 2015 - 2026 (USD Million) (Million Units)
14.1.7.3.3. Rest of South America Peanut Allergy Vaccine Market Overview, By Product, 2015 - 2026 (USD Million) (Million Units)
14.1.7.3.4. Rest of South America Peanut Allergy Vaccine Market Overview, By Drug Type, 2015 - 2026 (USD Million) (Million Units)
14.1.7.3.5. Rest of South America Peanut Allergy Vaccine Market Overview, By Route of Administration, 2015 - 2026 (USD Million) (Million Units)
14.1.7.3.6. Rest of South America Peanut Allergy Vaccine Market Overview, By Distribution channel, 2015 - 2026 (USD Million) (Million Units)
Chapter 15. Competitive Landscape
15.1. Competitive environment, 2017
15.2. Strategic framework
15.2.1. Partnership/collaborations/agreement
15.2.2. Expansion
15.2.3. Mergers & Acquisitions
15.2.4. New product development
Chapter 16. Key Vendor Analysis
16.1. Aimmune Therapeutics
16.1.1. Company overview
16.1.2. Financial performance
16.1.3. Product benchmarking
16.1.4. Recent initiatives
16.1.5. SWOT analysis
16.2. DBV Technologies
16.2.1. Company overview
16.2.2. Financial performance
16.2.3. Product benchmarking
16.2.4. Recent initiatives
16.2.5. SWOT analysis
16.3. Prota Therapeutics
16.3.1. Company overview
16.3.2. Financial performance
16.3.3. Product benchmarking
16.3.4. Recent initiatives
16.3.5. SWOT analysis
16.4. Cambridge Allergy
16.4.1. Company overview
16.4.2. Financial performance
16.4.3. Product benchmarking
16.4.4. Recent initiatives
16.4.5. SWOT analysis
16.5. Sanofi
16.5.1. Company overview
16.5.2. Financial performance
16.5.3. Product benchmarking
16.5.4. Recent initiatives
16.5.5. SWOT analysis
16.6. Aravax
16.6.1. Company overview
16.6.2. Financial performance
16.6.3. Product benchmarking
16.6.4. Recent initiatives
16.6.5. SWOT analysis
16.7. AnaptysBio
16.7.1. Company overview
16.7.2. Financial performance
16.7.3. Product benchmarking
16.7.4. Recent initiatives
16.7.5. SWOT analysis
16.8. Astellas Pharma
16.8.1. Company overview
16.8.2. Financial performance
16.8.3. Product benchmarking
16.8.4. Recent initiatives
16.8.5. SWOT analysis
16.9. Immunomic Therapeutics
16.9.1. Company overview
16.9.2. Financial performance
16.9.3. Product benchmarking
16.9.4. Recent initiatives
16.9.5. SWOT analysis
16.10. HAL Allergy
16.10.1. Company overview
16.10.2. Financial performance
16.10.3. Product benchmarking
16.10.4. Recent initiatives
16.10.5. SWOT analysis
Chapter 17. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Peanut Allergy Vaccine Market share, By Product Type, 2019 & 2026 (%)
10. Global Peanut Allergy Vaccine Market share, By ASP0892, By Product Type, 2015 & 2025 (USD Million)
11. Global Peanut Allergy Vaccine Market share, By AR101, By Product Type 2015 & 2025 (USD Million)
12. Global Peanut Allergy Vaccine Market share, By Others, By Product Type 2015 & 2025 (USD Million)
13. Global Peanut Allergy Vaccine Market share, By Application, 2019 & 2026 (%)
14. Global Peanut Allergy Vaccine Market share, By Hospitals, By Application, 2015 & 2025 (USD Million)
15. Global Peanut Allergy Vaccine Market share, By Personal Clinics, By Application 2015 & 2025 (USD Million)
16. Global Peanut Allergy Vaccine Market share, By Government Agencies, By Application, 2015 & 2025 (USD Million)
17. Global Peanut Allergy Vaccine Market share, By Others, By Application 2015 & 2025 (USD Million)
18. Global Peanut Allergy Vaccine Market share, By Drug Type, 2019 & 2026 (%)
19. Global Peanut Allergy Vaccine Market share, By Epinephrine Injection, By Drug Type, 2015 & 2025 (USD Million)
20. Global Peanut Allergy Vaccine Market share, By Antihistamines, By Drug Type, 2015 & 2025 (USD Million)
21. Global Peanut Allergy Vaccine Market share, By Route of Administration, 2019 & 2026 (%)
22. Global Peanut Allergy Vaccine Market share, By Oral, By Route of Administration, 2015 & 2025 (USD Million)
23. Global Peanut Allergy Vaccine Market share, By Injectable, By Route of Administration, 2015 & 2025 (USD Million)
24. Global Peanut Allergy Vaccine Market share, By Distribution Channels, 2019 & 2026 (%)
25. Global Peanut Allergy Vaccine Market share, By Retail Pharmacies, By Distribution Channels, 2015 & 2025 (USD Million)
26. Global Peanut Allergy Vaccine Market share, By Hospital Pharmacies, By Distribution Channels, 2015 & 2025 (USD Million)
27. Global Peanut Allergy Vaccine Market share, By Online Pharmacies, By Distribution Channels, 2015 & 2025 (USD Million)
28. Global Peanut Allergy Vaccine Market share, By Drug Store, By Distribution Channels, 2015 & 2025 (USD Million)
29. Global Peanut Allergy Vaccine Market share, By Region, 2019 & 2025 (%)
30. Global Peanut Allergy Vaccine Market share, By Region, 2015 - 2026(USD Million)
31. North America Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
32. North America Peanut Allergy Vaccine Market share, By Countries, 2019 & 2026 (%)
33. U.S. Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
34. Canada Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
35. Europe Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
36. Europe Peanut Allergy Vaccine Market share, By Countries, 2019 & 2026 (%)
37. Spain Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
38. UK Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
39. Italy Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
40. Germany Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
41. France Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
42. Rest of Europe Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
43. Asia-Pacific Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
44. Asia-Pacific Peanut Allergy Vaccine Market share, By Countries, 2019 & 2026 (%)
45. China Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
46. India Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
47. Australia Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
48. Japan Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
49. Rest of Asia-Pacific Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
50. Middle East & Africa Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
51. Middle East & Africa Peanut Allergy Vaccine Market share, By Countries, 2019 & 2026 (%)
52. GCC Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
53. South Africa Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
54. Rest of Middle East & Africa Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
55. Central & South America Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
56. Brazil Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
57. Mexico Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
58. Argentina Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
59. Rest of Central & South America Peanut Allergy Vaccine Market, 2015 - 2026(USD Million)
The Leading Key Players in Peanut Allergy Vaccine Market
Aimmune Therapeutics
DBV Technologies
Prota Therapeutics
Cambridge Allergy
Sanofi
Aravax
AnaptysBio
Astellas Pharma
Immunomic Therapeutics
HAL Allergy
others.
